{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:37:34Z","timestamp":1793929054038,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11899-025-00756-z","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T02:52:16Z","timestamp":1759978336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Inflammation in CMML Pathobiology and Progression"],"prefix":"10.1007","volume":"20","author":[{"given":"Niraj","family":"Neupane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"6","key":"756_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41375-021-01207-3","volume":"35","author":"O Chan","year":"2021","unstructured":"Chan O, Renneville A, Padron E. Chronic myelomonocytic leukemia diagnosis and management. Leukemia. 2021;35(6):1552\u201362.","journal-title":"Leukemia."},{"issue":"6","key":"756_CR2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ajh.27271","volume":"99","author":"MM Patnaik","year":"2024","unstructured":"Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. Am J Hematol. 2024;99(6):1142\u201365.","journal-title":"Am J Hematol."},{"issue":"1","key":"756_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41375-018-0203-0","volume":"33","author":"S Niyongere","year":"2019","unstructured":"Niyongere S, Lucas N, Zhou JM, Sansil S, Pomicter AD, Balasis ME, et al. Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia. 2019;33(1):205\u201316.","journal-title":"Leukemia."},{"issue":"6","key":"756_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","volume":"120","author":"L Barreyro","year":"2012","unstructured":"Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood. 2012;120(6):1290\u20138.","journal-title":"Blood."},{"issue":"8","key":"756_CR5","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1080\/10428194.2022.2056175","volume":"63","author":"AA Mangaonkar","year":"2022","unstructured":"Mangaonkar AA, Patnaik MM. Role of the bone marrow immune microenvironment in chronic myelomonocytic leukemia pathogenesis: novel mechanisms and insights into clonal propagation. Leuk Lymphoma. 2022;63(8):1792\u2013800.","journal-title":"Leuk Lymphoma."},{"issue":"23","key":"756_CR6","first-page":"2797","volume":"141","author":"HG Zhao","year":"2023","unstructured":"Zhao HG, Deininger M. Always stressed but never exhausted: how stem cells in myeloid neoplasms avoid extinction in inflammatory conditions. Blood. 2023;141(23):2797\u2013812.","journal-title":"Blood."},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"106511","DOI":"10.1016\/j.leukres.2021.106511","volume":"101","author":"G Montalban-Bravo","year":"2021","unstructured":"Montalban-Bravo G, Darbaniyan F, Kanagal-Shamanna R, Ganan-Gomez I, Class CA, Sasaki K, et al. Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemia. Leuk Res. 2021;101:106511.","journal-title":"Leuk Res."},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"5921392","DOI":"10.1155\/2018\/5921392","volume":"2018","author":"H Shi","year":"2018","unstructured":"Shi H, Wang Y, Li R, Xing W, Yang FC, Bai J, et al. Alteration in the Cytokine Secretion of Bone Marrow Stromal Cells from Patients with Chronic Myelomonocytic Leukemia Contribute to Impaired Hematopoietic Supportive Activity. Stem Cells Int. 2018;2018:5921392.","journal-title":"Stem Cells Int."},{"issue":"6","key":"756_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/leu.2013.355","volume":"28","author":"H Yang","year":"2014","unstructured":"Yang H, Bueso-Ramos C, DiNardo C, Estecio MR, Davanlou M, Geng QR, et al. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia. 2014;28(6):1280\u20138.","journal-title":"Leukemia."},{"issue":"1","key":"756_CR10","doi-asserted-by":"publisher","first-page":"2323212","DOI":"10.1080\/2162402X.2024.2323212","volume":"13","author":"M Bauer","year":"2024","unstructured":"Bauer M, J\u00e4kel N, Wilfer A, Haak A, Eszlinger M, Kelemen K, et al. Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML. Oncoimmunology. 2024;13(1):2323212.","journal-title":"Oncoimmunology."},{"issue":"5","key":"756_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","volume":"20","author":"S Pinho","year":"2019","unstructured":"Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019;20(5):303\u201320.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"756_CR12","doi-asserted-by":"crossref","unstructured":"Gal\u00e1n-D\u00edez M, Cuesta-Dom\u00ednguez \u00c1, Kousteni S. The Bone Marrow microenvironment in health and Myeloid Malignancy. Cold Spring Harb Perspect Med. 2018;8(7).","DOI":"10.1101\/cshperspect.a031328"},{"issue":"8","key":"756_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41577-024-00998-7","volume":"24","author":"JW Swann","year":"2024","unstructured":"Swann JW, Olson OC, Passegu\u00e9 E. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production. Nat Rev Immunol. 2024;24(8):596\u2013613.","journal-title":"Nat Rev Immunol."},{"issue":"4","key":"756_CR14","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4049\/jimmunol.2100168","volume":"207","author":"Y Sasaki","year":"2021","unstructured":"Sasaki Y, Guo YM, Goto T, Ubukawa K, Asanuma K, Kobayashi I, et al. IL-6 generated from human hematopoietic stem and progenitor cells through TLR4 signaling promotes emergency granulopoiesis by regulating transcription factor expression. J Immunol. 2021;207(4):1078\u201386.","journal-title":"J Immunol."},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"669363","DOI":"10.3389\/fcell.2021.669363","volume":"9","author":"ES Fasouli","year":"2021","unstructured":"Fasouli ES, Katsantoni E. JAK-STAT in early hematopoiesis and leukemia. Front Cell Dev Biol. 2021;9:669363.","journal-title":"Front Cell Dev Biol."},{"issue":"4","key":"756_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2014.01.007","volume":"14","author":"JL Zhao","year":"2014","unstructured":"Zhao JL, Ma C, O\u2019Connell RM, Mehta A, DiLoreto R, Heath JR, et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. Cell Stem Cell. 2014;14(4):445\u201359.","journal-title":"Cell Stem Cell."},{"issue":"25","key":"756_CR17","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1182\/blood-2012-10-460170","volume":"121","author":"E Padron","year":"2013","unstructured":"Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM, et al. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 2013;121(25):5068\u201377.","journal-title":"Blood."},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-immunol-081022-113627","volume":"41","author":"LG Ng","year":"2023","unstructured":"Ng LG, Liu Z, Kwok I, Ginhoux F. Origin and Heterogeneity of Tissue Myeloid Cells: A Focus on GMP-Derived Monocytes and Neutrophils. Annu Rev Immunol. 2023;41:375\u2013404.","journal-title":"Annu Rev Immunol."},{"issue":"5","key":"756_CR19","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2017.10.021","volume":"47","author":"A Y\u00e1\u00f1ez","year":"2017","unstructured":"Y\u00e1\u00f1ez A, Coetzee SG, Olsson A, Muench DE, Berman BP, Hazelett DJ, et al. Granulocyte-Monocyte progenitors and Monocyte-Dendritic cell progenitors independently produce functionally distinct monocytes. Immunity. 2017;47(5):890-902.e4.","journal-title":"Immunity."},{"issue":"4","key":"756_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","volume":"49","author":"M Guilliams","year":"2018","unstructured":"Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49(4):595\u2013613.","journal-title":"Immunity."},{"issue":"1","key":"756_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MOH.0000000000000689","volume":"29","author":"A Dhawan","year":"2022","unstructured":"Dhawan A, Padron E. Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia. Curr Opin Hematol. 2022;29(1):20\u20136.","journal-title":"Curr Opin Hematol."},{"issue":"23","key":"756_CR22","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1182\/blood-2015-01-620781","volume":"125","author":"D Selimoglu-Buet","year":"2015","unstructured":"Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125(23):3618\u201326.","journal-title":"Blood."},{"issue":"13","key":"756_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/blood-2016-12-753210","volume":"129","author":"C Talati","year":"2017","unstructured":"Talati C, Zhang L, Shaheen G, Kuykendall A, Ball M, Zhang Q, et al. Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis. Blood. 2017;129(13):1881\u20133.","journal-title":"Blood."},{"key":"756_CR24","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-48.","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"12","key":"756_CR25","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1038\/s41375-022-01727-6","volume":"36","author":"JJ Xu","year":"2022","unstructured":"Xu JJ, Chalk AM, Wall M, Langdon WY, Smeets MF, Walkley CR. Srsf2(P95H\/+) co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice. Leukemia. 2022;36(12):2883\u201393.","journal-title":"Leukemia."},{"issue":"14","key":"756_CR26","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-14-0739","volume":"75","author":"J Yamazaki","year":"2015","unstructured":"Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, et al. TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. Cancer Res. 2015;75(14):2833\u201343.","journal-title":"Cancer Res."},{"issue":"7569","key":"756_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525(7569):389\u201393.","journal-title":"Nature."},{"issue":"12","key":"756_CR28","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1158\/2159-8290.CD-24-0093","volume":"14","author":"NA Ben-Crentsil","year":"2024","unstructured":"Ben-Crentsil NA, Mohammed Ismail W, Balasis ME, Newman H, Quintana A, Binder M, et al. RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis. Cancer Discov. 2024;14(12):2509\u201331.","journal-title":"Cancer Discov."},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fonc.2018.00109","volume":"8","author":"T Picot","year":"2018","unstructured":"Picot T, Aanei CM, Flandrin Gresta P, Noyel P, Tondeur S, Tavernier Tardy E, et al. Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia. Front Oncol. 2018;8:109.","journal-title":"Front Oncol."},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.3389\/fimmu.2019.02052","volume":"10","author":"TP Hofer","year":"2019","unstructured":"Hofer TP, van de Loosdrecht AA, Stahl-Hennig C, Cassatella MA, Ziegler-Heitbrock L. 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes. Front Immunol. 2019;10:2052.","journal-title":"Front Immunol."},{"key":"756_CR31","doi-asserted-by":"crossref","unstructured":"Deschamps P, Wacheux M, Gosseye A, Morabito M, Pages A, Lyne AM, et al. CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia. J Clin Invest. 2024;134(22).","DOI":"10.1172\/JCI180738"},{"issue":"10","key":"756_CR32","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","volume":"33","author":"N Lucas","year":"2019","unstructured":"Lucas N, Duchmann M, Rameau P, Noel F, Michea P, Saada V, et al. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia. 2019;33(10):2466\u201380.","journal-title":"Leukemia."},{"issue":"2","key":"756_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00109-007-0262-6","volume":"86","author":"A Popov","year":"2008","unstructured":"Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med (Berl). 2008;86(2):145\u201360.","journal-title":"J Mol Med (Berl)."},{"issue":"12","key":"756_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3324\/haematol.2010.025924","volume":"95","author":"A Curti","year":"2010","unstructured":"Curti A, Trabanelli S, Onofri C, Aluigi M, Salvestrini V, Ocadlikova D, et al. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. Haematologica. 2010;95(12):2022\u201330.","journal-title":"Haematologica."},{"issue":"2","key":"756_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/jlb.66.2.252","volume":"66","author":"MC Dieu-Nosjean","year":"1999","unstructured":"Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol. 1999;66(2):252\u201362.","journal-title":"J Leukoc Biol."},{"issue":"20","key":"756_CR36","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","volume":"3","author":"A Franzini","year":"2019","unstructured":"Franzini A, Pomicter AD, Yan D, Khorashad JS, Tantravahi SK, Than H, et al. The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations. Blood Adv. 2019;3(20):2949\u201361.","journal-title":"Blood Adv."},{"issue":"2","key":"756_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000365877","volume":"133","author":"D Peker","year":"2015","unstructured":"Peker D, Padron E, Bennett JM, Zhang X, Horna P, Epling-Burnette PK, et al. A close association of autoimmune-mediated processes and autoimmune disorders with chronic myelomonocytic leukemia: observation from a single institution. Acta Haematol. 2015;133(2):249\u201356.","journal-title":"Acta Haematol."},{"issue":"6","key":"756_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1080\/10428194.2016.1243681","volume":"58","author":"MF Zahid","year":"2017","unstructured":"Zahid MF, Barraco D, Lasho TL, Finke C, Ketterling RP, Gangat N, et al. Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia. Leuk Lymphoma. 2017;58(6):1488\u201393.","journal-title":"Leuk Lymphoma."},{"key":"756_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.leukres.2016.05.013","volume":"47","author":"E Grignano","year":"2016","unstructured":"Grignano E, Mekinian A, Braun T, Liozon E, Hamidou M, Decaux O, et al. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. Leuk Res. 2016;47:136\u201341.","journal-title":"Leuk Res."},{"key":"756_CR40","doi-asserted-by":"publisher","first-page":"751630","DOI":"10.3389\/fimmu.2021.751630","volume":"12","author":"W Barcellini","year":"2021","unstructured":"Barcellini W, Fattizzo B. Immune phenomena in Myeloid Neoplasms: an \u201cEgg or Chicken\u201d question. Front Immunol. 2021;12.","journal-title":"Front Immunol."},{"issue":"2","key":"756_CR41","doi-asserted-by":"publisher","first-page":"101136","DOI":"10.1016\/j.beha.2019.101136","volume":"33","author":"AJ Ambinder","year":"2020","unstructured":"Ambinder AJ, Miller J, DeZern AE. Autoimmune disease in CMML-the chicken or the egg? Best Pract Res Clin Haematol. 2020;33(2).","journal-title":"Best Pract Res Clin Haematol."},{"key":"756_CR42","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1080\/10428194.2016.1243681","volume":"58","author":"MF Zahid","year":"2017","unstructured":"Zahid MF, Barraco D, Lasho TL, Finke C, Ketterling RP, Gangat N, et al. Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia. Leukemia Lymphoma. 2017;58:1488\u201393.","journal-title":"Leukemia Lymphoma."},{"issue":"6","key":"756_CR43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","volume":"23","author":"Z Cai","year":"2018","unstructured":"Cai Z, Kotzin JJ, Ramdas B, Chen S, Nelanuthala S, Palam LR, et al. Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis. Cell Stem Cell. 2018;23(6):833-49.e5.","journal-title":"Cell Stem Cell."},{"key":"756_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2017.12.004","volume":"59","author":"AR Migliaccio","year":"2018","unstructured":"Migliaccio AR. A vicious interplay between genetic and environmental insults in the etiology of blood cancers. Exp Hematol. 2018;59:9\u201313.","journal-title":"Exp Hematol."},{"key":"756_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","volume":"55","author":"AH Cull","year":"2017","unstructured":"Cull AH, Snetsinger B, Buckstein R, Wells RA, Rauh MJ. Tet2 restrains inflammatory gene expression in macrophages. Exp Hematol. 2017;55:56-70.e13.","journal-title":"Exp Hematol."},{"key":"756_CR46","doi-asserted-by":"publisher","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, et al. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130.","journal-title":"Int Immunopharmacol."},{"issue":"7","key":"756_CR47","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T. IL-6: regulator of Treg\/Th17 balance. Eur J Immunol. 2010;40(7):1830\u20135.","journal-title":"Eur J Immunol."},{"key":"756_CR48","doi-asserted-by":"crossref","unstructured":"Swatler J, Turos-Korgul L, Kozlowska E, Piwocka K. Immunosuppressive cell subsets and factors in Myeloid Leukemias. Cancers (Basel). 2021;13(6).","DOI":"10.3390\/cancers13061203"},{"issue":"7","key":"756_CR49","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/bloodadvances.2019032300","volume":"3","author":"AB Patel","year":"2019","unstructured":"Patel AB, Pettijohn EM, Abedin SM, Raps E, Deininger MW. Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations. Blood Adv. 2019;3(7):952\u20135.","journal-title":"Blood Adv."},{"key":"756_CR50","first-page":"100283","volume":"16","author":"S Gaur","year":"2021","unstructured":"Gaur S, Philipovskiy A, Orazi A. Post-operative hyperleukocytosis and leukostasis as the initial presentation of chronic myelomonocytic leukemia: a case report and review of literature. Leuk Res Rep. 2021;16.","journal-title":"Leuk Res Rep."},{"issue":"15","key":"756_CR51","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1158\/1078-0432.CCR-16-0372","volume":"22","author":"E Solary","year":"2016","unstructured":"Solary E. Unplugging JAK\/STAT in Chronic Myelomonocytic Leukemia. Clin Cancer Res. 2016;22(15):3707\u20139.","journal-title":"Clin Cancer Res."},{"key":"756_CR52","doi-asserted-by":"crossref","unstructured":"Naji NS, Sathish M, Karantanos T. Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia. Cancers (Basel). 2024;16(23).","DOI":"10.3390\/cancers16233974"},{"issue":"11","key":"756_CR53","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1080\/10428194.2023.2232492","volume":"64","author":"N Ramachandra","year":"2023","unstructured":"Ramachandra N, Gupta M, Schwartz L, Todorova T, Shastri A, Will B, et al. Role of IL8 in myeloid malignancies. Leuk Lymphoma. 2023;64(11):1742\u201351.","journal-title":"Leuk Lymphoma."},{"issue":"5","key":"756_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.leukres.2013.01.019","volume":"37","author":"MR Lopes","year":"2013","unstructured":"Lopes MR, Traina F, Campos Pde M, Pereira JK, Machado-Neto JA, Machado Hda C, et al. IL10 inversely correlates with the percentage of CD8\u207a cells in MDS patients. Leuk Res. 2013;37(5):541\u20136.","journal-title":"Leuk Res."},{"issue":"8","key":"756_CR55","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1177\/1753425920961157","volume":"26","author":"D Han","year":"2020","unstructured":"Han D, Tao J, Fu R, Shao Z. Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes. Innate Immun. 2020;26(8):703\u201315.","journal-title":"Innate Immun."},{"issue":"5","key":"756_CR56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/onco.13769","volume":"26","author":"D Tremblay","year":"2021","unstructured":"Tremblay D, Rippel N, Feld J, El Jamal SM, Mascarenhas J. Contemporary risk stratification and treatment of Chronic Myelomonocytic Leukemia. Oncologist. 2021;26(5):406\u201321.","journal-title":"Oncologist."},{"issue":"10","key":"756_CR57","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41375-021-01330-1","volume":"35","author":"A Renneville","year":"2021","unstructured":"Renneville A, Patnaik MM, Chan O, Padron E, Solary E. Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia. Leukemia. 2021;35(10):2739\u201351.","journal-title":"Leukemia."},{"issue":"15","key":"756_CR58","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1158\/1078-0432.CCR-15-2781","volume":"22","author":"E Padron","year":"2016","unstructured":"Padron E, Dezern A, Andrade-Campos M, Vaddi K, Scherle P, Zhang Q, et al. A multi-institution phase I trial of Ruxolitinib in patients with Chronic Myelomonocytic Leukemia (CMML). Clin Cancer Res. 2016;22(15):3746\u201354.","journal-title":"Clin Cancer Res."},{"key":"756_CR59","first-page":"162","volume":"130","author":"E Padron","year":"2017","unstructured":"Padron E, DeZern AE, Niyongere S, Ball MC, Balasis M, Ramadan H, et al. Promising results of a phase 1\/2 clinical trial of Ruxolitinib in patients with Chronic Myelomonocytic Leukemia. Blood. 2017;130:162.","journal-title":"Blood."},{"issue":"22","key":"756_CR60","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1158\/1078-0432.CCR-21-0935","volume":"27","author":"AM Hunter","year":"2021","unstructured":"Hunter AM, Newman H, Dezern AE, Steensma DP, Niyongere S, Roboz GJ, et al. Integrated human and Murine clinical study establishes clinical efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia. Clin Cancer Res. 2021;27(22):6095\u2013105.","journal-title":"Clin Cancer Res."},{"issue":"7","key":"756_CR61","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.2019004352","volume":"136","author":"MM Patnaik","year":"2020","unstructured":"Patnaik MM, Sallman DA, Mangaonkar AA, Heuer R, Hirvela J, Zblewski D, et al. Phase 1 study of lenzilumab, a recombinant anti-human GM-CSF antibody, for chronic myelomonocytic leukemia. Blood. 2020;136(7):909\u201313.","journal-title":"Blood."},{"key":"756_CR62","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1182\/blood-2024-202867","volume":"144","author":"D Hiwase","year":"2024","unstructured":"Hiwase D, Ross DM, Yeung DT, Yong ASM, Lane SW, Brown A, et al. Durable responses observed in Chronic Myelomonocytic Leukemia treated with Lenzilumab and Azacitidine. Blood. 2024;144:1006.","journal-title":"Blood."},{"issue":"1","key":"756_CR63","doi-asserted-by":"publisher","first-page":"9840","DOI":"10.1038\/s41467-024-54290-2","volume":"15","author":"JJ Rodriguez-Sevilla","year":"2024","unstructured":"Rodriguez-Sevilla JJ, Adema V, Chien KS, Loghavi S, Ma F, Yang H, et al. The IL-1\u03b2 inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial. Nat Commun. 2024;15(1):9840.","journal-title":"Nat Commun."},{"issue":"1","key":"756_CR64","doi-asserted-by":"publisher","first-page":"101244","DOI":"10.1016\/j.beha.2021.101244","volume":"34","author":"T Lasho","year":"2021","unstructured":"Lasho T, Patnaik MM. Novel therapeutic targets for chronic myelomonocytic leukemia. Best Pract Res Clin Haematol. 2021;34(1):101244.","journal-title":"Best Pract Res Clin Haematol."}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-025-00756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-025-00756-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-025-00756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:03:31Z","timestamp":1769051011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-025-00756-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s11899-025-00756-z","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}